Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–42.
Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA. 2020. Epub ahead of print.
Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Articles estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; [cited 2020 Apr 30]; Available from: www.thelancet.com/infection.
Xie J, Tong Z, Guan X, Du B, Qiu H, Slutsky AS. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020;46:837–40 Springer; Available from: https://pubmed.ncbi.nlm.nih.gov/32123994/.
Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020; [cited 2020 Jun 23]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32539537.
Couzin-Frankel J. The mystery of the pandemic’s ‘happy hypoxia’ [internet]. Science (80- ). 2020:455–6 [cited 2020 Jun 23]. American Association for the Advancement of Science; Available from: https://science.sciencemag.org/content/368/6490/455.
Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: a harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med. 2020; W.B. Saunders; [cited 2020 Jun 23]; Available from: https://pubmed.ncbi.nlm.nih.gov/32471783/.
Allali G, Marti C, Grosgurin O, Morélot-Panzini C, Similowski T, Adler D. Dyspnea: the vanished warning symptom of COVID-19 pneumonia. J Med Virol. 2020;jmv.26172 Wiley; [cited 2020 Jul 4]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.26172.
Xie J, Covassin N, Fan Z, Singh P, Gao W, Li G, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020; Elsevier; [cited 2020 Apr 19];0. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0025619620303670.
Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. Elsevier BV. 2020;0. Epub ahead of print.
Vaporidi K, Akoumianaki E, Telias I, Goligher EC, Brochard L, Georgopoulos D. Respiratory drive in critically ill patients pathophysiology and clinical implications. Am J Respir Crit Care Med. 2020;201:20–32 American Thoracic Society; [cited 2020 Apr 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31437406.
Epstein FH, Manning HL, Schwartzstein RM. Pathophysiology of dyspnea [internet]. Epstein FH, editor. N Engl J Med. 1995:1547–53 Massachusetts Medical Society ; [cited 2020 Apr 19]. Available from: http://www.nejm.org/doi/10.1056/NEJM199512073332307.
Costa R, Navalesi P, Cammarota G, Longhini F, Spinazzola G, Cipriani F, et al. Remifentanil effects on respiratory drive and timing during pressure support ventilation and neurally adjusted ventilatory assist. Respir Physiol Neurobiol. 2017;244:10–6 Elsevier B.V.
Corne S, Webster K, C Ginn GM, St-john W, Younes M. Medullary metastasis causing impairment of respiratory pressure output with intact respiratory rhythm. Am J Respir Crit Care Med. 1999; Available from: www.atsjournals.org.
Richards JB. Calculated decisions: mMRC (modified Medical Research Council) dyspnea scale. Emerg Med Pract. 2017;19:1–2 [cited 2020 Jun 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29068638.
Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2:257–66 British Medical Journal Publishing Group; [cited 2020 Jun 23]. Available from: https://www.bmj.com/content/2/5147/257.
Raux M, Ray P, Prella M, Duguet A, Demoule A, Similowski T. Cerebral cortex activation during experimentally induced ventilator fighting in normal humans receiving noninvasive mechanical ventilation. Anesthesiology. 2007;107:746–55 Lippincott Williams and Wilkins; [cited 2020 Apr 19]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18073550.
Esnault P, Roubin J, Cardinale M, D’Aranda E, Montcriol A, Cungi PJ, et al. Spontaneous hyperventilation in severe traumatic brain injury: incidence and association with poor neurological outcome. Neurocrit CareHumana Press Inc. 2019;30:405–13.
Hamilton RD, Winning AJ, Perry A, Guz A. Aerosol anesthesia increases hypercapnic ventilation and breathlessness in laryngectomized humans. J Appl Physiol. 1987;63:2286–92.
Manning HL, Shea SA, Schwartzstein RM, Lansing RW, Brown R, Banzett RB. Reduced tidal volume increases “air hunger” at fixed PCO2 in ventilated quadriplegics. Respir PhysiolElsevier. 1992;90:19–30.
Dempsey JA, Smith CA. Pathophysiology of human ventilatory control: number 6 in the series “physiology in respiratory medicine”. Eur Respir JEuropean Respiratory Society. 2014:495–512. Epub ahead of print.
Leusen IR. Chemosensitivity of the respiratory center; influence of CO2 in the cerebral ventricles on respiration. Am J Physiol. 1954;176:39–44.
Guyenet PG, Bayliss DA. Neural control of breathing and CO2 homeostasis. NeuronCell Press. 2015:946–61. Epub ahead of print.
Kvale PA, Conway WA, Coates EO. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. A clinical trial. Ann Intern Med. 1980;93:391–8.
Gandevia SC, Killian K, McKenzie DK, Crawford M, Allen GM, Gorman RB, et al. Respiratory sensations, cardiovascular control, kinaesthesia and transcranial stimulation during paralysis in humans. J Physiol. 1993;470:85–107 [cited 2020 Jun 23]. Available from: https://pubmed.ncbi.nlm.nih.gov/8308755/.
Easton PA, Slykerman LJ, Anthonisen NR. Ventilatory response to sustained hypoxia in normal adults. J Appl Physiol. 1986;61:906–11.
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia : different respiratory treatment for different phenotypes ? Intensive Care Med. 2020:1–6 Springer; [cited 2020 Apr 19]. Available from: https://www.esicm.org/wp-content/uploads/2020/04/684_author-proof.pdf.
Mchenry LC, Slocum HC, Bivens HE, Mayes HA, Hayes GJ. Hyperventilation in awake and anesthetized man: effects on cerebral blood flow and cerebral metabolism. Arch Neurol. 1965;12:270–7 American Medical Association; [cited 2020 Jun 23]. Available from: https://jamanetwork.com/journals/jamaneurology/fullarticle/565659.
Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology. 2015:196–205 Lippincott Williams and Wilkins; [cited 2020 Jun 23]. Available from: https://pubmed.ncbi.nlm.nih.gov/25401418/.
Wilkerson RG, Adler JD, Shah NG, Brown R. Silent hypoxia: a harbinger of clinical deterioration in patients with COVID-19. Am J Emerg Med. 2020; W.B. Saunders; [cited 2020 May 31]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735675720303909.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J MedMassachusetts Medical Society. 2020. Epub ahead of print.
D’Alonzo GE, Dantzker DR. Respiratory failure, mechanisms of abnormal gas exchange, and oxygen delivery. Med Clin North Am. 1983;67:557–71 [cited 2020 Apr 20]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6843220.
Ottestad W, Søvik S. COVID-19 patients with respiratory failure: what can we learn from aviation medicine? Br J AnaesthElsevier BV. 2020. Epub ahead of print.
Hamilton C, Steinlechner B, Gruber E, Simon P, Wollenek G. The oxygen dissociation curve: quantifying the shift. Perfusion. 2004;19:141–4 Sage PublicationsSage CA: Thousand Oaks, CA; [cited 2020 Apr 28]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15298420.
Woyke S, Rauch S, Ströhle M, Gatterer H. Modulation of Hb-O2 affinity to improve hypoxemia in COVID-19 patients. Clin NutrChurchill Livingstone. 2020. Epub ahead of print.
Sainburg RL, Clark AL, Billman GE, Schlader ZJ, Mündel T, Milne K, et al. Hypoxia, focus hypobaric hypoxia. Encycl Exerc Med Heal DisSpringer Berlin Heidelberg. 2012:428–31. Epub ahead of print.
Liu W, Hualan L. COVID-19:attacks the 1-Beta chain of hemoglobin and captures the porphyrin to inhibit human Heme metabolism. ChemRxiv. 2020. Epub ahead of print.
A-a O2 Gradient - MDCalc [Internet]. [cited 2020 Apr 30]. Available from: https://www.mdcalc.com/a-a-o2-gradient.
Park WB, Il JK, Kim G, Choi JP, Rhee JY, Cheon S, et al. Correlation between pneumonia severity and pulmonary complications in Middle East respiratory syndrome. J Korean Med SciKorean Academy of Medical Science. 2018:33. Epub ahead of print.
Barach AL, Martin J, Eckman M. Positive pressure respiration and its application to the treatment of acute pulmonary edema. Ann Intern MedAmerican College of Physicians. 1938;12:754.
Komorowski M, Aberegg SK. Using applied lung physiology to understand COVID-19 patterns. Br J Anaesth. 2020;0 Elsevier; [cited 2020 May 31]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0007091220303755.
Archer SL, Sharp WW, Weir EK. Differentiating COVID-19 pneumonia from acute respiratory distress syndrome (ARDS) and high altitude pulmonary edema (HAPE): therapeutic implications. CirculationOvid Technologies (Wolters Kluwer Health). 2020. Epub ahead of print.
Lang M, Som A, Mendoza DP, Flores EJ, Reid N, Carey D, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect DisLancet Publishing Group. 2020. Epub ahead of print.
Nagaraj C, Tabeling C, Nagy BM, Jain PP, Marsh LM, Papp R, et al. Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox. Eur Respir JEuropean Respiratory Society. 2017;50. Epub ahead of print.
Light RB. Pulmonary pathophysiology of pneumococcal pneumonia. Semin Respir Infect. 1999:218–26. Epub ahead of print.
van Heerden PV, Cameron PD, Karanovic A, Goodman MA. Orthodeoxia - an uncommon presentation following bilateral thoracic sympathectomy. Anaesth intensive care. SAGE PublicationsSage UK: London. England. 2003;31:581–3.
Gattinoni L, Coppola S, Cressoni M, Busana M, Chiumello D. Covid-19 does not Lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care MedAmerican Thoracic Society. 2020. Epub ahead of print.
Cheng H, Wang Y, Wang GQ. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med VirolJohn Wiley and Sons Inc. 2020. Epub ahead of print.
South AM, Diz D, Chappell MC. COVID-19, ACE2 and the cardiovascular consequences. Am J Physiol Heart Circ PhysiolNLM (Medline). 2020. Epub ahead of print.
Kickbusch I, Leung G. Response to the emerging novel coronavirus outbreak. BMJBMJ Publishing Group. 2020. Epub ahead of print.
Zhang H, Baker A. Recombinant human ACE2: acing out angiotensin II in ARDS therapy. Crit Care. 2017:305 BioMed Central Ltd. [cited 2020 Apr 28]. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1882-z.
Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J MedMassachusetts Medical Society. 2020. Epub ahead of print.
Wang S, Guo F, Liu K, Wang H, Rao S, Yang P, et al. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus ResElsevier. 2008;136:8–15.
Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev ImmunolNature Research. 2020:363–74. Epub ahead of print.
Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life SciScience in China Press. 2020;63:364–74.
Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J VirolAmerican Society for Microbiology. 2005;79:14614–21.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020; Journal of the American College of Cardiology; [cited 2020 Apr 20]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109720350087.
Guérin C, Matthay MA. Acute cor pulmonale and the acute respiratory distress syndrome. Intensive Care MedSpringer Verlag. 2016:934–6. Epub ahead of print.
Campbell CM, Kahwash R. Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis? [cited 2020 Apr 20]; Available from: http://ahajournals.org.
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020; [cited 2020 Apr 25]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32306492.
Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020; [cited 2020 Apr 26]; Available from: https://jamanetwork.com/journals/jama/fullarticle/2765302.
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb HaemostNLM (Medline). 2020. Epub ahead of print.
Monsalve-Naharro JÁ, Domingo-Chiva E, Castillo SG, Cuesta-Montero P, Jiménez-Vizuete JM. Inhaled nitric oxide in adult patients with acute respiratory distress syndrome. Farm HospSociedad Espanola de Farmacia Hospitalaria. 2017:292–312. Epub ahead of print.
Luo W, Yu H, Gou J, Li X, Sun Y, Li J, et al. Title: clinical pathology of critical patient with novel coronavirus pneumonia (COVID-19) list of authors; 2020. Preprints; Available from: www.preprints.org.
Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S-Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–4[cited 2020 May 31]. Available from. https://doi.org/10.1016/j.jtho.2020.02.010.
Whyte CS, Morrow GB, Mitchell JL, Chowdary P, Mutch NJ. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020;jth.14872 [cited 2020 Apr 25]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14872.
Di Marco F, Devaquet J, Lyazidi A, Galia F, Da Costa NP, Fumagalli R, et al. Positive end-expiratory pressure-induced functional recruitment in patients with acute respiratory distress syndrome. Crit Care MedLippincott Williams and Wilkins. 2010;38:127–32.
Hopkins SR. Exercise induced arterial hypoxemia: the role of ventilation-perfusion inequality and pulmonary diffusion limitation. Adv Exp Med BiolSpringer New York. 2006:17–30. Epub ahead of print.
Mason RJ. Pathogenesis of COVID-19 from a cell biologic perspective. Eur Respir J. 2020; European Respiratory Society; [cited 2020 Apr 20]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32269085.
Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care MedNLM (Medline). 2020. Epub ahead of print.
Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24:154 BioMed Central; [cited 2020 Apr 19]. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-02880-z.
Ottestad W, Seim M, Mæhlen JO. Covid-19 med stille hypoksemi. Tidsskr Nor LaegeforenNLM (Medline). 2020;140. Epub ahead of print.
Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA - J Am Med AssocAmerican Medical Association. 2020. Epub ahead of print.
Spyropoulos AC, Ageno W, Barnathan ES. Hospital-based use of thromboprophylaxis in patients with COVID-19. Lancet. 2020;0 Elsevier; [cited 2020 Apr 25]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620309260.
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, et al. Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost. 2020; [cited 2020 Apr 25]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32267998.
Tarry D, Powell M. Hypoxic pulmonary vasoconstriction. BJA Educ. 2017;17:208–13 Oxford Academic.
Meng L, Qiu H, Wan L, Ai Y, Xue Z, Guo Q, et al. Intubation and ventilation amid the COVID-19 outbreak. AnesthesiologyOvid Technologies (Wolters Kluwer Health). 2020;1. Epub ahead of print.
Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ. Respiratory support in novel coronavirus disease (COVID-19) patients, with a focus on resource-limited settings. Am J Trop Med Hyg. 2020; [cited 2020 Apr 25]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32319424.
Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159–68 Massachussetts Medical Society. [cited 2020 Apr 25]. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1214103.
Elharrar X, Trigui Y, Dols A-M, Touchon F, Martinez S, Prud’homme E, et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMAAmerican Medical Association (AMA). 2020. Epub ahead of print.
Caputo ND, Strayer RJ, Levitan R. Early self-Proning in awake, non-intubated patients in the emergency department: a single ED’s experience during the COVID-19 pandemic. Kline J, editor. Acad Emerg Med. 2020;27:375–8 Blackwell Publishing Inc.; [cited 2020 May 31]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/acem.13994.
Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit CareBioMed Central Ltd. 2020;24. Epub ahead of print.
Slessarev M, Cheng J, Ondrejicka M, Arntfield R. Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia. Can J AnesthSpringer. 2020:1. Epub ahead of print.
Monsalve-Naharro JÁ, Domingo-Chiva E, Castillo SG, Cuesta-Montero P, Jiménez-Vizuete JM. Inhaled nitric oxide in adult patients with acute respiratory distress syndrome. Farm Hosp. 2017:292–312 Sociedad Espanola de Farmacia Hospitalaria; [cited 2020 Apr 25]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28236803.